Sign in
Active, not recruitingPhase 4

Bicarbonate for the treatment of cardiac arrest

Key facts

Who runs it
Aarhus University Hospital
Where
Denmark21 sites in 1 countryChoose a country to see its sites
Status
Active, not recruiting
Phase
Phase 4
People taking part
778 people, planned
Started
6 Feb 2023
Ended
31 Oct 2026
Type of study
Interventional
Record updated
2 October 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • In-hospital cardiac arrest
  • Age ≥ 18 years
  • Received at least one dose of adrenaline during cardiopulmonary resuscitation

Who cannot take part

  • Clearly documented “do-not-resuscitate” order prior to the cardiac arrest
  • Prior enrollment in the trial
  • Invasive mechanical circulatory support at the time of the cardiac arrest
  • Known or suspected pregnancy at the time of the cardiac arrest
  • Known objection by the patient to participate in the trial
  • Clinical indication for bicarbonate administration

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To determine whether sodium bicarbonate, as compared to placebo, when administered during in-hospital cardiac arrest, will increase return of spontaneous circulation.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Bicarbonate for In-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled Trial
Record updated
2 October 2024